Israel Englander Rhythm Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 36,977 shares of RYTM stock, worth $2.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,977

Holding current value

$2.08 Million

% of portfolio

0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$40.81 - $55.0 $1.51 Million - $2.03 Million	36,977 New	36,977 $1.94 Million
Q4 2023 Feb 14, 2024	BUY	$21.39 - $49.64 $745,035 - $1.73 Million	34,831 New	34,831 $1.6 Million
Q1 2023 May 15, 2023	BUY	$16.88 - $34.24 $8.52 Million - $17.3 Million	504,608 Added 1192.98%	546,906 $9.76 Million
Q4 2022 Feb 14, 2023	BUY	$22.21 - $30.25 $939,438 - $1.28 Million	42,298 New	42,298 $1.23 Million
Q2 2022 Aug 15, 2022	BUY	$3.12 - $12.25 $401,010 - $1.57 Million	128,529 Added 35.64%	489,121 $2.03 Million
Q1 2022 May 16, 2022	BUY	$6.13 - $12.24 $287,423 - $573,909	46,888 Added 14.95%	360,592 $4.15 Million
Q4 2021 Feb 14, 2022	BUY	$8.62 - $13.9 $834,243 - $1.35 Million	96,780 Added 44.61%	313,704 $3.13 Million
Q3 2021 Nov 15, 2021	BUY	$11.68 - $20.72 $702,061 - $1.25 Million	60,108 Added 38.33%	216,924 $2.83 Million
Q2 2021 Aug 16, 2021	SELL	$18.52 - $22.55 $253,927 - $309,183	-13,711 Reduced 8.04%	156,816 $3.07 Million
Q1 2021 May 17, 2021	BUY	$20.25 - $39.49 $3.45 Million - $6.73 Million	170,527 New	170,527 $3.63 Million
Q1 2020 May 14, 2020	SELL	$13.16 - $22.9 $293,112 - $510,051	-22,273 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$19.53 - $25.5 $4.26 Million - $5.56 Million	-218,155 Reduced 90.74%	22,273 $511,000
Q3 2019 Nov 14, 2019	BUY	$18.62 - $24.51 $4.11 Million - $5.41 Million	220,573 Added 1110.92%	240,428 $5.19 Million
Q2 2019 Aug 14, 2019	BUY	$21.11 - $28.48 $246,522 - $332,589	11,678 Added 142.82%	19,855 $437,000
Q1 2019 May 14, 2019	BUY	$24.76 - $31.66 $202,462 - $258,883	8,177 New	8,177 $224,000
Q4 2018 Feb 14, 2019	SELL	$24.11 - $31.34 $462,767 - $601,539	-19,194 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$26.99 - $35.85 $251,222 - $333,691	-9,308 Reduced 32.66%	19,194 $560,000
Q2 2018 Aug 14, 2018	BUY	$17.02 - $35.2 $485,104 - $1 Million	28,502 New	28,502 $891,000

Others Institutions Holding RYTM

# of Institutions

191

Shares Held

67.3M

Call Options Held

834K

Put Options Held

78.6K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account